0000899243-15-003144.txt : 20150814 0000899243-15-003144.hdr.sgml : 20150814 20150814160530 ACCESSION NUMBER: 0000899243-15-003144 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150814 DATE AS OF CHANGE: 20150814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001273636 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593553710 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11801 RESEARCH DRIVE STREET 2: SUITE D CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 386-462-2204 MAIL ADDRESS: STREET 1: 11801 RESEARCH DRIVE STREET 2: SUITE D CITY: ALACHUA STATE: FL ZIP: 32615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chulay Jeffrey D. CENTRAL INDEX KEY: 0001598537 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36370 FILM NUMBER: 151055686 MAIL ADDRESS: STREET 1: C/O APPLIED GENETIC TECHNOLOGIES CORP. STREET 2: 11801 RESEARCH DRIVE, SUITE D CITY: ALACHUA STATE: FL ZIP: 32615 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2015-06-30 0 0 1 0001273636 APPLIED GENETIC TECHNOLOGIES CORP AGTC 0001598537 Chulay Jeffrey D. C/O APPLIED GENETIC TECHNOLOGIES CORP. 11801 RESEARCH DRIVE, SUITE D ALACHUA FL 32615 0 1 0 0 VP and Chief Medical Officer Common Stock 2014-11-13 4 M 0 2277 3.50 A 7277 D Common Stock 2015-01-29 4 M 0 2500 0.35 A 7277 D Common Stock 2015-03-09 4 M 0 2500 0.35 A 7277 D Stock Option (Right to Buy) 3.50 2014-11-13 4 M 0 2277 0.00 D 2017-05-31 Common Stock 10305 8028 D Stock Option (Right to Buy) 0.35 2015-01-29 4 M 0 2500 0.00 D 2023-01-06 Common Stock 35511 30511 D Stock Option (Right to Buy) 0.35 2015-03-09 4 M 0 2500 0.00 D 2023-01-06 Common Stock 33011 30511 D The option, representing a right to purchase a total of 10,305 shares, is fully-vested and exercisable for 100% of the underlying shares. The option, representing a right to purchase a total of 35,511 shares, vests in equal monthly installments over four years, resulting in the option becoming exercisable for 100% of the underlying shares on the fourth anniversary of the date of grant. /s/ Hemmie Chang, attorney-in-fact for Jeffrey D. Chulay 2015-08-14